Table 5.
Naive Analysis: Estimated Effectiveness of Bedaquiline Duration on Successful End-of-Treatment Outcome, endTB (Expand New Drug Markets for TB) Cohort, 2015–2018
BDQ Duration | n | Successful Outcome [n (%)] | Adjusted SR (95% CI) |
---|---|---|---|
6 mo | 538 | 470 (87.4) | Ref. |
7–11 mo | 272 | 215 (79) | 0.93 (0.88–0.99) |
⩾12 mo | 658 | 603 (91.6) | 1.09 (1.05–1.14) |
Definition of abbreviations: BDQ = bedaquiline; CI = confidence interval; Ref = reference; SR = success ratio.